Navigation Links
Ceregene Presents Long Term Follow-Up Data From Phase 1 Trial of,CERE-120 Demonstrating Improved Motor Function in Parkinson's,Patients

ells affected by Parkinson's disease, as well as an excellent safety profile over a wide range of CERE-120 dose levels."

About Phase 2 Trial of CERE-120 Currently Underway

A double-blind, controlled Phase 2 clinical trial is now enrolling 51 patients with advanced Parkinson's disease at nine medical centers in the United States, with two thirds of patients being enrolled in the active treatment group and one third in the control group. Patients are receiving CERE-120 via stereotactic neurosurgery to deliver the drug into the putamen region of the brain. Patients will be followed for 12 months for safety and efficacy. Contacts at the medical centers involved in this study can be found through a link on the Ceregene web site: www.ceregene.com.

About CERE-120

CERE-120 is composed of an adeno-associated virus (AAV) vector carrying the gene for neurturin (NTN), a naturally occurring protein known to repair damaged and dying dopamine-secreting neurons, keeping them alive and functioning normally. NTN is a member of the same protein family as glial cell-derived neurotrophic factor (GDNF). The two molecules have similar pharmacological properties, and both have been shown to benefit the midbrain dopamine neurons that degenerate in Parkinson's disease and are responsible for the major motor impairments. CERE-120 is delivered by stereotactic injection to the affected area of the brain, providing stable, long-lasting expression of NTN in a highly targeted fashion. Ceregene owns exclusive technology and product rights to CERE-120.

About Parkinson's disease

Parkinson's disease is a progressive movement disorder that affects at least one million people in the United States. It is caused by a reduction in dopamine containing nerve cells of the midbrain. Dopamine is a neurotransmitter involved in controlling movement and coordination, so Parkinson's patients experiencing a reduction of
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the Treatment of Alzheimers Disease
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
4. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
5. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
6. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
7. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
8. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
9. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
10. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
11. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein

Post Your Comments:
(Date:11/7/2009)...AMI BEACH, Fla., Nov. 7 Patients r... is an effective therapy in treating acute swellin... serious genetic disorder, according to data prese..., Asthma & Immunology (ACAAI) Annual Meeting. ...tients conducted in parallel with the ongoing, pro...
(Date:11/6/2009).... LOUIS, Nov. 6 Recessio...to depress sales for Allied Healthcare Products in...ember 30, 2009. ,, Sales declines pushed Allied...e quarter was about $745,000, or negative 9 cents ...er of about $208,000, or 3 cents per share. ,,...
(Date:11/6/2009)...RRISTOWN, N.J., Nov. 6 W...ng specialty pharmaceutical company, announced tod...executive officer, will provide an overview and up...e 18th Annual Healthcare Conference on Wednesday, ...e. ,, This presentation will be webcast live an...
Breaking Medicine Technology:Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 2Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 3Recession Continues to Depress Sales at Allied Healthcare Products 2Recession Continues to Depress Sales at Allied Healthcare Products 3Recession Continues to Depress Sales at Allied Healthcare Products 4Recession Continues to Depress Sales at Allied Healthcare Products 5Recession Continues to Depress Sales at Allied Healthcare Products 6Life Sciences 26 Health Care Companies Unprepared for Information Security Risks 3A Deloitte Survey 52415 1Life Sciences 26 Health Care Companies Unprepared for Information Security Risks 3A Deloitte Survey 52415 2Life Sciences 26 Health Care Companies Unprepared for Information Security Risks 3A Deloitte Survey 52415 3Life Sciences 26 Health Care Companies Unprepared for Information Security Risks 3A Deloitte Survey 52415 4Aflac Incorporated To Release Second Quarter Results on July 29 2009 52413 1Aflac Incorporated To Release Second Quarter Results on July 29 2009 52413 2Ochsner Health System Relies on Trend Micro Enterprise Security for Immediate Protection and Lower Complexity 52412 1Ochsner Health System Relies on Trend Micro Enterprise Security for Immediate Protection and Lower Complexity 52412 2Ochsner Health System Relies on Trend Micro Enterprise Security for Immediate Protection and Lower Complexity 52412 3
...GRAND RAPIDS, Mich., Dec. 15 Van Andel Institute ...hnology to measure on a large,scale the presence o...orn,infants to screen for health-threatening condi...cted from 1998 to 2004 and the latest RNA technolo...s in each sample, and to,quantify the levels of se...
...New Company Founded on Mayo Clinic Discoveries is ...ers and Hair Growth Using Nano-Materials with Angi... OmegaGenesis today unveiled the company,s novel ...ade of rare earth elements with angiogenic propert... foot ulcers and hair growth are being developed b...
Other Medicine Technology:Infant Blood May Provide Insights into Diseases Present at Birth 2Infant Blood May Provide Insights into Diseases Present at Birth 3OmegaGenesis Unveils Novel Nanotechnology Platform With Broad Biomedical Applications 2OmegaGenesis Unveils Novel Nanotechnology Platform With Broad Biomedical Applications 3
(Date:11/8/2009)...ke you out of the game later, doctors say , ...ries are the talk of the NFL this season, sidelini...ng back Willie Parker. , Officials at the Ameri...demy of Podiatric Sports Medicine are warning athl...l sports like football and lacrosse. , "Many fa...
(Date:11/8/2009)... 3D Global Solutions is pleased to announce that ...posal effort for ReSound who recently received an ...ontract. The award includes not only the Veterans ... and other federal agencies. , ...Global Solutions is pleased to announce that it ha...
(Date:11/8/2009)... not mean the battle is won," said Dr. Charmaine Y...wire/ -- In a vote of 240-194, the Stupak-Ellswort... to prohibit abortion mandates and funding in HR 3...ted for Life Action President and CEO Dr. Charmain...victory for the pro-life Americans across this cou...
(Date:11/8/2009)... The following was rele...escue Insurrecta Nex. ,, Mr. Terry and his ass... to keep child-killing by abortion out of any heal...This is a great first step to victory -- a touchdo...ghting ahead of us. Our rejoicing must be tempered...
(Date:11/7/2009)... Karen Ignagni, Preside...IP), released the following statement today on Hou...gly support comprehensive health care reform, and ...g a complete overhaul of how health insurance is p... coverage, elimination of pre-existing condition e...
Breaking Medicine News(10 mins):Health News:Rx for Fall Foot Injuries 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2Health News:AHIP Statement on House Passage of H.R. 3962 2
...s shows lower heart rate when moms-to-be work out ... News) -- Exercise does a body good -- two bodies ...new study shows that when a mom-to-be works out, h...tal Biology 2008 annual meeting in San Diego. , "T...
... can play an essential role in the most serious he...g intensive or end of life care, according to rese... Clinical Nursing. , Canadian researchers spent ...le with terminal illnesses. , They concluded th...
...ve Event Deemed a Success by Attendees, BLACKWOOD...ntly held their first Healthcare Educational Forum...t Medical Center (WFUBMC). This event took,place i...tion systems across the United States participated...
...l, April 7, 2008 Parents who want their babies to...-sleeping arrangements or feeding their children e... Universit de Montral study published in the April...ey reach four to six years old. , Some 987 mother...
...N, Fla., April 8, 2008 It,s common knowledge,that...ic disease as they,age. Heart disease is the leadi...ond. The statistics are staggering: one in two men...,literally be a silver bullet in preventing severa...
... to Henry Ford Health System, MSU, U-M, Wayne Stat...gan researchers whose,work has helped improve heal...ional research dollars totaling $50,000 through Bl...an State,University, University of Michigan and Wa...
Other Medicine News:Health News:Humor plays an important role in healthcare even when patients are terminally ill 2Health News:Humor plays an important role in healthcare even when patients are terminally ill 3Health News:Metrologic and Wake Forest University Baptist Medical Center Sponsored Healthcare Educational Forum 2Health News:Metrologic and Wake Forest University Baptist Medical Center Sponsored Healthcare Educational Forum 3Health News:Sleep, baby, sleep: parents' behavior has direct impact on children’s slumber 2Health News:Dr. William S. Gruss, M.D., Says That Medical Research Shows You Can Reduce Your Risk of Cancer By Up To 77% and Reverse the Effects of Aging in A CARDIOLOGIST'S GUIDE TO ... ANTI-AGING, ANTIOXIDANTS & RESVERATROL 2Health News:Researchers Able to Continue their Work to Help Patients Thanks to McDevitt Excellence in Research Awards from Blue Cross Blue Shield of Michigan Foundation 2
ART REACHMicroPoint Design
... tips. Each box contains 1000 tips (5 bags of 200 ...bags of 50 tips). Also available in easy-to-open, ...Packs are sealed with a tamper-proof strip which c...amond Tips. Bulk Packs are closed using the rapid-...
1 mL Pipette Tip
Finntip Wide 100-1000ul
Medicine Products: